The Opioid Crisis: A Prescription for Intense Oversight, Investigations and Litigation - On Demand Recording
Recorded On: 04/26/2018
Time: 90 minutes
Session Format: On Demand Recording
Opioid addiction does not discriminate based on gender, age, or race, and its devastating effects on communities throughout the United States have propelled the opioid crisis to the top of the agenda for state and federal regulators, legislators, prosecutors and civil litigants. According to FDA Commissioner Dr. Scott Gottlieb:
"[W]e are facing an opioid epidemic “a public health crisis, and we must take all necessary steps to reduce the scope of opioid misuse and abuse. We will continue to take regulatory steps when we see situations where an opioid product's risks outweigh its benefits, not only for its intended patient population but also in regard to its potential for misuse and abuse."
Controlled Substances, Rampant Litigation Beyond the human toll, the litigation and enforcement implications of the crisis are vast. Unlike prior industry-wide litigation, opioid litigation threatens stakeholders at every level of the distribution chain, including medical academia, accreditation bodies, pharmacy boards, manufacturers, distributors, formularies, PBMs, dispensers, retailers, importers, on-line marketers, hospitals, medical facilities, prescribing physicians, payors, employers, and members of the consuming public.
Panel members will offer an overview of this burgeoning body of litigation and investigative activity and will provide insight into how the crisis has unfolded, where the litigation and oversight activities currently stand, and what to expect going forward.
Level of Difficulty: Intermediate
Intermediate-level programs generally offer focused discussions regarding common legal issues pertaining to the program topic. Intermediate programs include legal updates and changes in the law. Speakers will assume the audience has a working knowledge of this specialty of health law, and there will be limited review of the fundamentals. This program is designed to provide a targeted, comprehensive analysis of the subject matter for those practicing law in this specialty for three to seven years and/or those whose practice is periodically focused in the covered subject area.
- AHLA Member: $145
- Non-AHLA Member: $275
Sponsoring AHLA Group:
- Hospitals and Health Systems
Co-Sponsoring AHLA Group:
- Health Care Liability and Litigation
- Behavioral Health Task Force
Patricia A. Markus
Scott R. Grubman
Chilivis Cochran Larkins & Bever LLP
Michael A. Walsh
Strasburger & Price, L.L.P.
On-Demand+CLE webinars are eligible for Continuing Legal Education (CLE) credit and are approved in every state with mandatory CLE requirements for attorneys unless otherwise specified. Please refer to the Distance Learning CLE State Chart for details regarding specific state guidelines.
Offerings designated as “On-Demand" differ from those designated as “On-Demand+CLE" in that they are CLE-ineligible. However, CLE credit may be obtained by applying directly to the attorney's state accrediting body, but approval is not guaranteed and is at the discretion of said accrediting body and subject to its rules and regulations. Please refer to the Distance Learning CLE State for details regarding specific state guidelines.
Other, Non-CLE Credits
AHLA On-Demand+CLE webinars are only approved for CLE credits unless otherwise stated. To obtain other credit types (Continuing Professional Education, Compliance Certification Board, Nursing Home Administrator, etc.) participants may apply directly their desired licensing body, but approval is not guaranteed and is at the discretion of said licensing body and subject to its rules and regulations.
For additional information about Distance Learning-related credits, please email the Practice Groups staff at firstname.lastname@example.org.
It is recommended that you use a high speed/broadband internet connect (Wifi is not recommended), a PC with Windows and Internet Explorer 11 or higher. If you are using a Mac, please use the Safari web browser.